LENZ
USDLENZ Therapeutics Inc. Common Stock
$28.050+1.120 (4.159%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$26.930
High
$28.400
Low
$26.790
Volume
0.68M
Company Fundamentals
Market Cap
849.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.80M
Exchange
NMS
Currency
USD
52-Week Range
Low $16.535Current $28.050High $50.4
Related News
GlobeNewswire
LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025
SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (NASDAQ:LENZ), a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1.44%, the first and
View more
Analyst Upgrades
Piper Sandler Maintains Overweight on LENZ Therapeutics, Raises Price Target to $67
Piper Sandler analyst Biren Amin maintains LENZ Therapeutics with a Overweight and raises the price target from $51 to $67.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.